Skip to content

GIRISHYA

Active Private limited companyfounded 2023active for 3 yearsRue de la Peupleraie 15, 5310 EghezéeKBO/BCE: BE 0800.311.366

Lifetime

3 annual accounts with figures on one time axis
peak of €32,940 in 2023
€28,937▲ 24.5%
lowest -€49,508 in 2025
-€49,508▼ €59,628
peak of €29,447 in 2024
-€20,061▼ €49,508
€57,555▲ 114%
Board1 name since 2023
1 director
Documentsfilings and deeds
27-03-2026126 days before the deadline
2025micro format
Gross margin from €23,247 to €28,937Loss of €49,508Equity from €29,447 to -€20,061Debts from €26,832 to €57,555

Key points

from the 2025 annual accounts

Equity

-€20,061
202320242025

Debts exceed assets in financial year 2025.

Result

-€49,508 -€49,508
€10,1002024-€49,5002025

From profit to loss in 2025, after a profit of €10,120 in 2024.

Turnover

≈ €89,000 estimated

The micro format states no turnover.

Debts

€57,555 154% of the balance sheet
Financial debts 19%Suppliers 1%Taxes and wages 0%Other 80%

Of this, €46,714 falls due within a year.

Liquidity

0.44 was 3.37 in 2024

Short-term debts rose from €9,499 to €46,714.

Position in the sector

-53.5%

Lower solvency than 95% of companies in human health. Sector median 63.1% · 21,368 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 7,655 companies had the same profile as GIRISHYA has now. Each dot stands for 20 companies, two years later.

84.7%
were still trading
5.8%
stopped another way
8.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more

Another 0.7% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 7,655 companies, not a prediction for GIRISHYA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 05-04-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0800311366
Registered office moved from Hannut to Eghezée The registered office moved from Avenue Paul Brien 32-4280 Hannut to n°15 rue de la Peupleraie à 5310 Eghezée · Board meeting of 02-09-2024 · Gazette deed
Incorporation Founding capital of €100, 100 shares · Founded by · appointed as director · published on 05-04-2023 · Gazette deed
First establishment Rue Artoisenet 2, Namur
All 8 events

Comparable companies

same main activity, similar in size and age
Company
GIRISHYA Eghezée €37,493 €28,937 -53.5% -
CAVASTA MEDICAL Profondeville €39,713 €28,617 83.8% -
DOCTEUR CHARLOTTE LOISEAU Soignies €33,536 €28,675 70.6% -
HENRYA Woluwe-Saint-Lambert €36,656 €25,848 66.6% -
Dr. GEYPEN LORE Halle €43,264 €28,779 98.9% -
Dr. Sofie De Smet Bruges €40,320 €33,631 7.1% -
MB MED Trooz €40,281 €33,793 74.5% -

These companies have the same main activity as GIRISHYA: general medical practice (NACE 86210). They are comparable in size and age: total assets between €33,500 and €43,300, founded between 2022 and 2024.

Official details

Source: KBO
Status
Active since 03-04-2023Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.346.946.8705000 Namur, since 03-04-2023
Financial year end
31 December
Peppol
Reachable since 07-10-2025
Company details

Annual accounts 2025

€37,493▼ 33.4%
Filing
Filed on 27-03-2026, 126 days before the end of the filing period
Financials

Insights on GIRISHYA

GIRISHYA files the micro format. That format states no turnover. The gross margin fell from €32,940 in 2023 to €28,937 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about GIRISHYA

What is the company number of GIRISHYA?
The company number of GIRISHYA is 0800.311.366. The VAT number is the same number with BE in front: BE 0800.311.366.
Where is GIRISHYA based?
The registered office is at Rue de la Peupleraie 15, 5310 Eghezée.Company details
What does GIRISHYA do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of GIRISHYA?
GIRISHYA is a private limited company (BV).
When was GIRISHYA founded?
GIRISHYA was founded on 03-04-2023.
Is GIRISHYA still active?
Yes, GIRISHYA is an active enterprise in the KBO register.
What is the turnover of GIRISHYA?
The turnover in financial year 2025 is ≈ €89,000. This figure is estimated from the gross margin of €28,937 and 47 comparable companies (NACE 86). It probably lies between €64,000 and €130,000.Financials
Is GIRISHYA profitable?
In financial year 2025, GIRISHYA made a loss of €49,508.
Where can I find the annual accounts of GIRISHYA?
GIRISHYA filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of GIRISHYA due?
GIRISHYA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.